Pyridazinone compounds

Details for Australian Patent Application No. 2005316396 (hide)

Owner Anadys Pharmaceuticals, Inc.

Inventors Zhou, Yuefen; Webber, Stephen E.; Li, Liansheng

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005316396

PCT Pub. Number WO2006/066079

Priority 60/636,616 17.12.04 US

Filing date 16 December 2005

Wipo publication date 22 June 2006

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066079 Priority application(s): WO2006/066079

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316397-3, 5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof

2005316384-RNAi modulation of MLL-AF4 and uses thereof